Table of Contents Table of Contents
Previous Page  394 / 2894 Next Page
Information
Show Menu
Previous Page 394 / 2894 Next Page
Page Background

and cytoprotective mechanisms. Br J Anaesth

91:551–565, 2003.

55. Zaugg M,Lucchinetti E,Garcia C,et al:Anaesthetics

and cardiac preconditioning. Part II. Clínicas impli-

cations. Br J Anaesth 91:566–576, 2003.

56. Tanaka K, Ludwig LM, Kersten JR, et al: Mecha-

nisms of cardioprotection by volatile anesthetics.

Anesthesiology 100:707–721, 2004.

57. De Hert SG, Turani F, Mathur S, et al: Cardioprotec-

tion with volatile anesthetics: Mechanisms and clí-

nicas implications. Anesth Analg 100:1584–1593,

2005.

58. Schlack W, Preckel B, Stunneck D, et al: Effects of

halothane, enflurane, isoflurane, sevoflurane and

desflurane on myocardial reperfusion injury in the

isolated rat heart. Br J Anaesth 81:913–919, 1998.

59. Patel HH, Ludwig LM, Fryer RM, et al: Delta opioid

agonists and volatile anesthetics facilitate cardiopro-

tection via potentiation of K

ATP

channel opening.

FASEB J 16:1468–1470, 2002.

60. Ludwig LM, Weihrauch D, Kersten JR, et al: Protein

kinase C translocation and Src protein tyrosine

kinase activation mediate isoflurane-induced pre-

conditioning in vivo: Potential downstream targets

of mitochondrial K

ATP

channels and reactive oxygen

species. Anesthesiology 100:532–539, 2004.

61. Zhong C, Zhou Y, Liu H: Nuclear factor

k

B and

anesthetic preconditioning during myocardial

ischemia-reperfusion. Anesthesiology 100:540–

546, 2004.

62. Hausenloy DJ,Yellon DM: New directions for pro-

tecting the heart against ischaemia-reperfusion

injury: Targeting the reperfusion injury salvage

kinase (RISK)-pathway. Cardiovasc Res 61:448–

460, 2004.

63. Inagaki N, Gonoi T, Clement JP, et al: Reconstitu-

tion of IK

ATP

: An inward rectifier subunit plus the

sulfonylurea receptor. Science 270:1166–1170,

1995.

64. Suzuki M, Sasaki N, Miki T, et al: Role of sarcolem-

mal K

ATP

channels in cardioprotection against ische-

mia/reperfusion injury in mice. J Clin Invest

109:509–516, 2002.

65. Sato T, Sasaki N, Seharaseyon J, et al: Selective

pharmacological agents implicate mitochondrial

but not sarcolemmal K

ATP

channels in ischemic

cardioprotection. Circulation 101:2418–2423,

2000.

66. Dos Santos P, Kowaltowski AJ, Laclau MN, et al:

Mechanisms by which opening the mitochondrial

ATP-sensitive K

+

channel protects the ischemic

heart. Am J Physiol Heart Circ Physiol 283:H284–

H295, 2002.

67. Holmuhamedov EL, Wang L, Terzic A: ATP-sen-

sitive K

+

channel openers prevent Ca

2+

overload

in rat cardiac mitochondria. J Physiol 519:347–

360, 1999.

68. Green DR, Reed JC: Mitochondria and apoptosis.

Science 281:1309–1312, 1998.

69. Gottlieb RA, Engler RL: Apoptosis in myocardial

ischemia-reperfusion. Ann N Y Acad Sci 874:412–

426, 1999.

70. Ozcan C, Bienengraeber M, Dzeja PP, et al:

Potassium channel openers protect cardiac

mitochondria by attenuating oxidant stress at

reoxygenation. Am J Physiol Heart Circ Physiol

282:H531–H539, 2002.

71. Minners J, Lacerda L, McCarthy J, et al: Ischemic

and pharmacological preconditioning in Girardi

cells and C2C12 myotubes induce mitochondrial

uncoupling. Circ Res 89:787–792, 2001.

72. Halestrap AP: The regulation of the matrix volume

of mammalian mitochondria in vivo and in vitro

and its role in the control of mitochondrial metabo-

lism. Biochim Biophys Acta 973:355–382, 1989.

73. Garlid KD: Cation transport in mitochondria—the

potassium cycle. Biochim Biophys Acta 1275:123–

126, 1996.

74. Holmuhamedov EL, Jovanovic S, Dzeja PP, et al:

Mitochondrial ATP-sensitive K

+

channels modulate

cardiac mitochondrial function. Am J Physiol Heart

Circ Physiol 275:H1567–H1576, 1998.

75. Costa AD, Quinlan CL, Andrukhiv A, et al: The

direct physiological effects of mitochondrial K

ATP

opening on heart mitochondria.Am J Physiol Heart

Circ Physiol 290:H406–H415, 2006.

76. Sergeev P, da Silva R, Lucchinetti E, et al: Trigger-

dependent gene expression profiles in cardiac pre-

con

ditioning:Evidence

for distinct genetic programs

in ischemic and anesthetic preconditioning. Anes-

thesiology 100:474–488, 2004.

77. Tanaka K,Weihrauch D,Ludwig LM,et al: Mitochon-

drial adenosine triphosphate–regulated potassium

channel opening acts as a trigger for isoflurane-indu-

ced preconditioning by generating reactive oxygen

species. Anesthesiology 98:935–943, 2003.

78. Roscoe AK,Christensen JD,Lynch C 3rd: Isoflurane,

but not halothane, induces protection of human

myocardium via adenosine A

1

receptors and adeno-

sine triphosphate–sensitive potassium channels.

Anesthesiology 92:1692–1701, 2000.

79. Toller WG, Gross ER, Kersten JR, et al: Sarcolemmal

and mitochondrial adenosine triphosphate–depen-

dent potassium (K

ATP

) channels. Mechanism of

desflurane-induced cardioprotection. Anesthesio-

logy 92:1731–1739, 2000.

80. Hanouz JL, Yvon A, Massetti M, et al: Mechanisms

of desflurane-induced preconditioning in isolated

human right atria in vitro. Anesthesiology 97:33–41,

2002.

81. Kwok WM, Martinelli AT, Fujimoto K, et al: Diffe-

rential modulation of the cardiac adenosine tri-

phosphate–sensitivepotassiumchannelbyisoflurane

and halothane. Anesthesiology 97:50–56, 2002.

82. Han J, Kim E, Ho WK, et al: Effects of volatile anes-

thetic isoflurane on ATP-sensitive K

+

channels in

rabbit ventricular myocytes. Biochem Biophys Res

Commun 229:852–856, 1996.

83. Aizawa K, Turner LA, Weihrauch D, et al: Protein

kinase C-

ε

primes the cardiac sarcolemmal adeno-

sine triphosphate–sensitive potassium channel to

modulation by isoflurane.Anesthesiology 101:381–

389, 2004.

84. Turner LA, Fujimoto K, Suzuki A, et al: The interac-

tion of isoflurane and protein kinase C–activators

on sarcolemmal K

ATP

channels. Anesth Analg

100:1680–1686, 2005.

85. An J, Stadnicka A, Kwok WM, et al: Contribution

of reactive oxygen species to isoflurane-induced

sensitization of cardiac sarcolemmal adenosine

triphosphate–sensitive potassium channel to

pinacidil. Anesthesiology 100:575–580, 2004.

86. Stadnicki A, Bosjnak ZJ: Isoflurane decreases ATP

sensitivity of guinea pig cardiac sarcolemmal KATP

channel at reduced intracellular pH. Anesthesio-

logy 98:396–403, 2003.

87. Marinovic J, Bosjnak ZJ, Stadnicka A: Distinct roles

of sarcolemmal and mitochondial adenosine tri-

phosphate–sensitive potassium channels in isoflura-

ne-induced protection against oxidative stress.

Anesthesiology 105:98–104, 2006.

88. Marinovic J, Bosnjak ZJ, Stadnicka A: Preconditio-

ning by isoflurane induces lasting sensitization of

the cardiac sarcolemmal adenosine triphosphate–

sensitive potassium channel by a protein kinase

C-

d

–mediated

mechanism.

Anesthesiology

103:540–547, 2005.

89. Stadnicka A, Marinovic J, Bienengraeber M, et al:

Impact of in vivo preconditioning by isoflurane on

adenosine triphosphate–sensitive potassium chan-

nels in the rat heart: Lasting modulation of nucleo-

tide sensitivity during early memory period.

Anesthesiology 104:503–510, 2006.

90. Bienengraeber M, Warltier DC, Bosnjak ZJ, et al:

Mechanism of cardiac sarcolemmal adenosine tri-

phosphate–sensitive potassium channel activation

by isoflurane in a heterogenous expression system.

Anesthesiology 105:534–540, 2006.

91. Kohro S, Hogan QH, Nakae Y, et al: Anesthetic

effects on mitochondrial ATP-sensitive K channel.

Anesthesiology 95:1435–1440, 2001.

92. Nakae Y, Kwok WM, Bosnjak ZJ, et al: Isoflurane

activates rat mitochondrial ATP-sensitive K

+

chan-

nels reconstituted in lipid bilayers. Am J Physiol

Heart Circ Physiol 284:H1865–H1871, 2003.

93. Nakae Y, Kohro S, Hogan QH, et al: Intracellular

mechanismof mitochondrial adenosine triphospha-

te–sensitive potassium channel activation with iso-

flurane. Anesth Analg 97:1025–1032, 2003.

94. Gross GJ, Peart JN: K

ATP

channels and myocardial

preconditioning: An update. Am J Physiol Heart

Circ Physiol 285:H921–H930, 2003.

95. Crystal GJ, Zhou X, Gurevicius J, et al: Direct coro-

nary vasomotor effects of sevoflurane and desflurane

in in situ canine hearts. Anesthesiology 92:1103–

1113, 2000.

96. Piriou V, Ross S, Pigott D, et al: Beneficial effect of

concomitant administration of isoflurane and nico-

randil. Br J Anaesth 79:68–77, 1997.

97. TollerWG,Kersten JR,Gross ER,et al: Isoflurane pre-

conditions myocardium against infarction via activa-

tion of inhibitory guanine (G

i

) nucleotide binding

proteins. Anesthesiology 92:1400–1407, 2000.

98. Kersten JR, Orth KG, Pagel PS, et al: Role of adeno-

sine in isoflurane-induced cardioprotection. Anes-

thesiology 86:1128–1139, 1997.

99. Wakeno-Takahashi M, Otani H, Nakao S, et al: Ade-

nosine and a nitric oxide donor enhances cardio-

protection by preconditioning with isoflurane

through mitochondrial adenosine triphosphate–

sensitive K

+

channel-dependent and -independent

mechanisms. Anesthesiology 100:515–524, 2004.

100. Ishizawa Y, Pidikiti R, Liebman PA, et al: G protein–

coupled receptors as direct targets of inhaled anes-

thetics. Mol Pharmacol 61:945–952, 2002.

101. Lange M, Smul TM, Blomeyer CA, et al: Role of the

b

1

-adrenergic pathway in anesthetic and ischemic

preconditioning against myocardial infarction in

the rabbit heart in vivo. Anesthesiology 105:503–

510, 2006.

102. Liu H, McPherson BC, Yao Z: Preconditioning atte-

nuates apoptosis and necrosis: Role of protein

kinase C-epsilon and -delta isoforms. Am J Physiol

Heart Circ Physiol 281:H404–H410, 2001.

103. Toller WG, Montgomery MW, Pagel PS, et al: Isoflu-

rane-enhanced recovery of canine stunned myocar-

dium: Role for protein kinase C? Anesthesiology

91:713–722, 1999.

104. Fujimoto K, Bosnjak ZJ, Kwok WM: Isoflurane-

induced facilitation of the cardiac sarcolemmal K

ATP

channel. Anesthesiology 97:57–65, 2002.

105. Light PE, Bladen C, Winkfein RJ, et al: Molecular

basis of protein kinase C–induced activation of

ATP-sensitive potassium channels. Proc Natl Acad

Sci USA 97:9058–9063, 2000.

106. Uecker M,Da Silva R,Grampp T,et al: Translocation

of protein kinase C isoforms to subcellular targets

in ischemic and anesthetic preconditioning. Anes-

thesiology 99:138–147, 2003.

107. Novalija E, Kevin LG, Camara AK, et al: Reactive

oxygen species precede the epsilon isoform of

protein kinase C in the anesthetic preconditio-

ning signaling cascade. Anesthesiology 99:421–

428, 2003.

108. Obal D, Weber NC, Zacharowski K, et al: Role of

protein kinase C-

ε

in isoflurane-induced cardiopro-

tection. Br J Anaesth 94:166–173, 2005.

109. Toma O,Weber NC,Wolter JI, et al: Desflurane pre-

conditioning induces time-dependent activation of

protein kinase C epsilon and extracellular-signal

regulated kinase 1 and 2 in the rat heart in vivo.

Anesthesiology 101:1372–1380, 2004.

110. Bouwman RA, Musters RJ, van Beek-Harmsen BJ,

et al: Reactive oxygen species precede protein

394

Farmacología y anestesia

II